← Back to Search

Educational Media Interventions for Cancer (ADELANTE Trial)

N/A
Recruiting
Led By Lisa Kachnic, MD
Research Sponsored by Columbia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients with non-metastatic prostate or breast cancer
Karnofsky performance status 70 or greater
Timeline
Screening 3 weeks
Treatment Varies
Follow Up following completion of rt (4-6 weeks from enrollment for breast cancer, 4-9 weeks for prostate cancer), for up to 5 years
Awards & highlights

ADELANTE Trial Summary

This trial is studying how well educational media interventions work in preparing Latinx Spanish-speaking patients for radiation therapy for breast or prostate cancer and in fostering receptivity to and informed decision-making around cancer clinical trial participation.

Who is the study for?
This trial is for Latinx Spanish-speaking individuals with a confirmed diagnosis of non-metastatic breast or prostate cancer. They must have a Karnofsky performance status of 70 or above, indicating they are able to care for themselves. Women who can bear children need pregnancy tests as per guidelines. Participants should be planning to receive or currently undergoing curative radiation therapy and must consult using a certified interpreter.Check my eligibility
What is being tested?
The study is testing educational media interventions designed to help Latinx patients understand radiation therapy for breast or prostate cancer and encourage informed participation in clinical trials. It includes an audiovisual education program on radiation therapy and brochures from ASTRO and NCI about cancer treatments and research studies.See study design
What are the potential side effects?
Since this trial focuses on educational materials rather than medical treatments, there are no direct side effects related to drugs or therapies being tested. However, participants may experience emotional responses to the information provided.

ADELANTE Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My cancer has not spread beyond my prostate or breast.
Select...
I am able to care for myself but cannot do normal activities without help.
Select...
I have been diagnosed with prostate or breast cancer through a tissue examination.

ADELANTE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~following completion of rt (4-6 weeks from enrollment for breast cancer, 4-9 weeks for prostate cancer), for up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and following completion of rt (4-6 weeks from enrollment for breast cancer, 4-9 weeks for prostate cancer), for up to 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Radiation Therapy (RT) Adherence Score
Radiation Therapy (RT) Knowledge Questionnaire
Radiation Therapy (RT) Satisfaction Questionnaire
Secondary outcome measures
Clinical Trials Perceptivity Questionnaire
Clinical trial enrollment

ADELANTE Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: Audiovisual Intervention- Radiation Therapy EducationExperimental Treatment1 Intervention
Audiovisual video will be provided to the subjects as educational material.
Group II: Audiovisual Intervention- Cancer Clinical TrialsExperimental Treatment1 Intervention
Audiovisual video will be provided to the subjects as educational material.
Group III: Written Brochure- Radiation Therapy EducationActive Control1 Intervention
Written brochures will be provided to the subjects as educational material.
Group IV: Written Brochure- Cancer Clinical TrialsActive Control1 Intervention
Written brochures will be provided to the subjects as educational material.

Find a Location

Who is running the clinical trial?

VarianUNKNOWN
4 Previous Clinical Trials
186 Total Patients Enrolled
Columbia UniversityLead Sponsor
1,433 Previous Clinical Trials
2,447,019 Total Patients Enrolled
29 Trials studying Breast Cancer
23,639 Patients Enrolled for Breast Cancer
Varian Medical SystemsIndustry Sponsor
58 Previous Clinical Trials
3,499 Total Patients Enrolled
2 Trials studying Breast Cancer
322 Patients Enrolled for Breast Cancer

Media Library

Audiovisual Intervention- Cancer Clinical Trials Education Clinical Trial Eligibility Overview. Trial Name: NCT05351424 — N/A
Breast Cancer Research Study Groups: Written Brochure- Radiation Therapy Education, Audiovisual Intervention- Cancer Clinical Trials, Written Brochure- Cancer Clinical Trials, Audiovisual Intervention- Radiation Therapy Education
Breast Cancer Clinical Trial 2023: Audiovisual Intervention- Cancer Clinical Trials Education Highlights & Side Effects. Trial Name: NCT05351424 — N/A
Audiovisual Intervention- Cancer Clinical Trials Education 2023 Treatment Timeline for Medical Study. Trial Name: NCT05351424 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the enrollment process for this experiment currently open?

"Clinicaltrials.gov indicates that this medical research project is actively recruiting patients, with the first posting having been on May 3rd 2022 and the most recent update being 10 days later."

Answered by AI

How many study participants are participating in this research?

"Yes. According to the clinicaltrials.gov database, this clinical trial is actively recruiting applicants; it was first posted on May 3rd 2022 and most recently updated a week later. The study requires 240 participants to be recruited from 2 different medical sites."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad Onc
Lisa A. Kachnic 2022. "AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad Onc". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05351424.
All > Breast Cancer Hawaii > Prostate Cancer
~62 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top